Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Progressive Pulmonary Fibrosis: full-pipeline trial registry
6 of 8 indexed Progressive Pulmonary Fibrosis trials are currently recruiting.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 6 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Progressive Pulmonary Fibrosis: 8 US clinical trials tracked, 6 recruiting.
Progressive Pulmonary Fibrosis is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Avalyn Pharma, running 2 of these trials.
Enrollment posture brief
Registry condition progressive-pulmonary-fibrosis
OPEN 6 | RECR 75% | LATE 3 | EARLY 3 | RANK #2176 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adolescent Idiopathic Scoliosis (75% recruiting · 8 trials)
Progressive Pulmonary Fibrosis lists 6 open slots (75% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Progressive Pulmonary Fibrosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Progressive Pulmonary Fibrosis is recruiting above its size-band peers.
6 of 8 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Progressive Pulmonary Fibrosis research.
Avalyn Pharma accounts for 2 of 8 trials (25%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Progressive Pulmonary Fibrosis enrolment sits around 500 participants.
Median target enrolment is 500 among the 8 trials that report a genuine target (sentinel values excluded). 1 of those (12.5%) plan for fewer than 100 participants.
-
Progressive Pulmonary Fibrosis research is mostly interventional.
7 interventional and 1 observational studies make up this index (87.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Boehringer Ingelheim
NCT06238622
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
United Therapeutics
NCT05943535
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
University of Massachusetts, Worcester
NCT06855329
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Avalyn Pharma
NCT06329401
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Avalyn Pharma
NCT06951217
SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
Medical University of South Carolina
NCT07269262
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Bristol-Myers Squibb
NCT06025578
Xenon MRI and Progressive ILD
Duke University
NCT05241275
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Progressive Pulmonary Fibrosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Progressive Pulmonary Fibrosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Progressive Pulmonary Fibrosis page
8 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Progressive Pulmonary Fibrosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Avalyn Pharma sponsors the most Progressive Pulmonary Fibrosis trials on record, review their full trial history before evaluating a specific study. See Avalyn Pharma's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Progressive Pulmonary Fibrosis condition card totals 8 registered trials; most-linked intervention BMS-986278 Placebo; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.